Finance

Lists
524731:BOM
Jenburkt Pharmaceuticals Ltd
916,05 INR
+0,01%
(+0,050) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524731...
Open
942,00 INR
High
952,45 INR
Low
916,05 INR
Mkt. cap
4,69 млд
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 INR
52-wk low
880,10 INR
EPS
74,40 INR
Shares outstanding
4,59 млн
No. of employees
801
Open
942,00 INR
High
952,45 INR
Low
916,05 INR
Mkt. cap
4,69 млд
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 INR
52-wk low
880,10 INR
EPS
74,40 INR
Shares outstanding
4,59 млн
No. of employees
801
News stories
From web sources and news partners
About Jenburkt Pharmaceuticals Ltd
CEO-
Employees801
Founded1985
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 6-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
355,12 млн / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
455,58 млн
430,24 млн
446,32 млн
355,12 млн
Cost of goods sold
83,56 млн
87,89 млн
101,21 млн
63,22 млн
Cost of revenue
83,56 млн
87,89 млн
101,21 млн
63,22 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139,32 млн
147,14 млн
95,15 млн
130,25 млн
Operating expense
248,41 млн
276,38 млн
191,98 млн
238,04 млн
Total operating expenses
331,97 млн
364,27 млн
293,19 млн
301,26 млн
Operating income
123,60 млн
65,97 млн
153,13 млн
53,86 млн
Other non operating income
20,79 млн
18,15 млн
-60,40 млн
15,13 млн
EBT including unusual items
143,32 млн
82,97 млн
137,08 млн
67,69 млн
EBT excluding unusual items
143,32 млн
82,97 млн
171,23 млн
67,69 млн
Income tax expense
41,69 млн
23,65 млн
28,59 млн
8,84 млн
Effective tax rate
29,09%
28,51%
20,85%
13,05%
Other operating expenses
101,64 млн
120,92 млн
88,74 млн
101,38 млн
Net income
101,63 млн
59,31 млн
108,49 млн
58,86 млн
Net profit margin
22,31%
13,79%
24,31%
16,57%
Earnings per share
-
-
-
-
Interest and investment income
-
-
57,47 млн
-
Interest expense
-1,07 млн
-1,16 млн
-392,00 миң
-1,30 млн
Net interest expenses
-1,07 млн
-1,16 млн
57,07 млн
-1,30 млн
Depreciation and amortization charges
7,44 млн
8,32 млн
8,09 млн
6,41 млн
EBITDA
130,94 млн
71,11 млн
158,72 млн
59,45 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору